Mr. Erol Toksöz entered the pharmaceutical sector in 1976 when he founded Ankara Galenos Pharmaceutical Wholesaler, laying the foundations for Sanovel to be established in 1983. Ever since the day it was founded, the firm has been developing products without compromising the values that it wholeheartedly adheres to. With every passing day, Sanovel strives to gain knowledge and experience, staying updated, relevant, and agile in the transforming pharmaceutical landscape. Thereby adding value to every stage of production by valuing patients, the environment and its entire workforce.
Sanovel began its production journey in Şişli / Istanbul with a small team of five people. It is now 1,200+ with the firm growing larger and more powerful each day. Sanovel currently owns a modern production and R&D facility comprising 59,000 square metre covered area nestled within a plot of 125,000 square metres, where it carries out its production to global standards through innovation.
Sanovel has also expanded beyond the national borders and is available globally, taking its place in the global market. The firm now aims to advance our country's pharmaceutical sector with the same passion with which it was established, embracing development, change, new ideas, and innovation.
Sanovel was founded through 100% local funding and for more than 30 years, has worked on enabling a healthy future. According to IQVIA industry analytics data, we are one of the ten biggest companies in terms of turnover within the pharmaceutical industry.
Sanovel Pharmaceutical laid the foundations for its new pharmaceutical manufacturing facility on the 3rd November, 2001 in Çantaköy (Silivri, Istanbul) and began full production in April, 2006. Sanovel’s facility, accredited by national and international regulatory bodies, aims to increase production capacity and open gates to overseas trade.
The production facility consists of the main production unit, the cephalosporin production unit, purification unit, R&D centre, warehouse, and social infrastructures. The production capacity in a single shift amounts to 300 million boxes. Sanovel is one of the ten biggest firms in the Turkish pharmaceutical sector, manufacturing products using the most advanced technologies, in strict accordance with the latest Good Manufacturing Practice standards issued by the World Health Organisation.
Sanovel, along with its staff who are experts in their field, qualified workforce and innovative R&D team, produces solutions for the needs of modern medicine with agility. Alongside a local and international stance, it provides direction to the Turkish pharmaceutical industry with a roadmap towards a strong brand recognition in international markets.
Sanovel is working towards creating more impact and value for patients across the world, striving with all its ability to build a healthy future.